Regional Head, Pharmacovigilance Quality (PVQA)

Novartis; Sabadell; Hybride; EUR 69 000 - 128 000; Plein temps

Résumé du poste

Novartis in Barcelona, Spain, is seeking a Regional PV QA Head to provide end-to-end quality assurance vigilance expertise for global and local PV and Device Vigilance activities. The role leads regional quality oversight, CAPA management, and inspection readiness to ensure safety and regulatory compliance of Novartis products.

The position focuses on regional and country quality systems, development and execution of the Global Vigilance Quality Plan, and collaboration with PS & PV teams to

Responsabilités

• Drive regional and country quality oversight for implementation and maintenance of Vigilance Quality Systems implementation.
• Ensure PV regulations compliance and monitor country/regional quality performance.
• Coordinate the Global Vigilance Quality Plan deliverables with regional activities.
• Monitor indicators on performance, compliance and quality of vigilance systems.
• Propose quality improvements and lead regional quality initiatives.
• Support CAPA development and management for PV audits and inspections.
• Prepare for Health Authority vigilance inspections and manage CAPA evidence.

Description du poste

Salary Range:

€69,100.00 - €128,300.00

Job Description Summary

#LI-Hybrid

Location: Barcelona, Spain

This role is based in Barcelona, Spain. Novartis is unable to offer relocation support for this role. Please only apply if this location is accessible for you.

The Regional PV QA Head provides end to end quality assurance vigilance expertise and support to global and local operational Pharmacovigilance (PV) and Device Vigilance activities within Novartis with a focus on the country organizations, as well as quality expertise in regional and local vigilance regulation, in order to ensure compliance with applicable regulatory requirements and Novartis procedures.

Job Description

Major Accountabilities:

• Drive independently the regional and country quality oversight for implementation and maintenance of Novartis vigilance Quality Systems performed by the local teams, namely Quality Issue, proactive risk assessment and action management systems.
• Ensure, together with PS and PV in Countries and Regions team, that regional and country quality performance of the Novartis Vigilance System tasks and responsibilities is performed as required under global, regional and country PV regulations, to monitor that safety of the Novartis authorized products are met, and changes to their risk-benefit balance are identified.
• Support the regional and country Global Research and Development Quality management cycle through development, execution and accountability for deliverables of the global vigilance Quality Plan (QP). Coordinate execution of the QP with relevance to applicable regional and country patient safety activities and report the status to applicable Global PV QA team.
• Monitor indicators that relate to the performance, compliance and quality of regional and country vigilance systems, in line with indicators defined by Global PV QA team. Act as a quality champion by communicating risks to PS and PV and providing recommendations on potential mitigations Promptly communicate regional and country compliance issues to Global PS&PV, PV QA management and QPPV.
• Proactively propose potential quality improvement measures and develop strategies aimed at simplifying processes and improving quality of outputs while ensuring compliance with regulatory requirements; share best practice within and across regions. Lead regional initiatives focused on quality improvement and compliance, provide ongoing project support and governance, as assigned.
• Provide expertise and support Global PV QA team in the execution of vigilance Quality Risk Assessments (QRA) to identify and mitigate regional and country PV risks. Support maintenance of the Novartis global Pharmacovigilance System Master File (PSMF), where applicable.
• Ensure a constant state of regional and country vigilance inspection readiness. In line with Global PV QA and PS&PV teams, prepare for, facilitate, provide expertise and lead logistics for Health Authority (HA) vigilance inspections, assess results of pre-inspection activities and HA inspection findings in terms of associated risks and communicate to management. Perform Quality check of vigilance inspection deliverables. Align with PS and PV team and review the inspection corrective and preventive (CAPA) plan, to ensure quality, consistency and appropriateness of commitments. Act as the functional QA approver of inspection CAPA plans from the PV inspections in country organizations in the QMS Monitor the status of implementation of the CAPAs and approve the related evidence in the QMS, to ensure they are completed, appropriately documented and sustainable.
• Expertly guide the development of robust and sustainable CAPAs to address PV audit findings related to country organizations and act as functional QA approver of the CAPA plan in the QMS. Monitor the status of implementation of CAPAs to ensure they are completed, appropriately documented and sustainable and approve applicable related evidence in the QMS
• Provide expertise and support country PS and PV and other business partners with identification and compliance of-Quality Issue investigations, act as functional QA in the QMS and ensure timely escalation of applicable Quality Issues to management; provide assistance in the remediation of PV system issues; ensure follow-up and monitoring of completeness of CAPAs in alignment with PV QA team.
• Oversee definition of PV self-assessment plans from Regional PS & PV team to regional and country pharmacovigilance processes as well as their execution. Review vigilance self-assessment reports and approve related action plans in the QMS
• Identify regional and local training needs (for example via Quality Issues) and deliver knowledge sharing sessions that meet the needs of business and QA partners and improve overall quality and compliance of the Vigilance system.
• Provide guidance and recommendations on Merger & Acquisition as well as divestment relevant activities for integration or disintegration of the vigilance system, where appli